[go: up one dir, main page]

MX2012012523A - Lactonas esteroideas anticancerigenas insaturadas en la posicion 7(8). - Google Patents

Lactonas esteroideas anticancerigenas insaturadas en la posicion 7(8).

Info

Publication number
MX2012012523A
MX2012012523A MX2012012523A MX2012012523A MX2012012523A MX 2012012523 A MX2012012523 A MX 2012012523A MX 2012012523 A MX2012012523 A MX 2012012523A MX 2012012523 A MX2012012523 A MX 2012012523A MX 2012012523 A MX2012012523 A MX 2012012523A
Authority
MX
Mexico
Prior art keywords
anticancer
unsaturated
steroidal lactones
lactones
steroidal
Prior art date
Application number
MX2012012523A
Other languages
English (en)
Inventor
Andres Francesch Solloso
Jose Fernando Reyes Benitez
Maria Del Carmen Cuevas Marchante
Rogelio Fernandez Rodriguez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44544049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012012523(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MX2012012523A publication Critical patent/MX2012012523A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Un compuesto de fórmula general I: (Ver Formula) en la que R1-R17 y la línea -------tienen diversos significados para su uso en el tratamiento del cáncer.
MX2012012523A 2010-04-27 2011-04-26 Lactonas esteroideas anticancerigenas insaturadas en la posicion 7(8). MX2012012523A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10382095 2010-04-27
PCT/EP2011/056566 WO2011134954A1 (en) 2010-04-27 2011-04-26 Anticancer steroidal lactones unsaturated in position 7 (8)

Publications (1)

Publication Number Publication Date
MX2012012523A true MX2012012523A (es) 2012-12-17

Family

ID=44544049

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012523A MX2012012523A (es) 2010-04-27 2011-04-26 Lactonas esteroideas anticancerigenas insaturadas en la posicion 7(8).

Country Status (28)

Country Link
US (1) US8962602B2 (es)
EP (1) EP2563803B1 (es)
JP (1) JP5815675B2 (es)
KR (1) KR101855453B1 (es)
CN (1) CN102947322B (es)
AU (1) AU2011247634B2 (es)
BR (1) BR112012027393B1 (es)
CA (1) CA2797468C (es)
CL (1) CL2012003006A1 (es)
CY (1) CY1117541T1 (es)
DK (1) DK2563803T3 (es)
ES (1) ES2574205T3 (es)
HR (1) HRP20160523T1 (es)
HU (1) HUE028751T2 (es)
IL (1) IL222707B (es)
ME (1) ME02488B (es)
MX (1) MX2012012523A (es)
MY (1) MY162934A (es)
NZ (1) NZ603261A (es)
PL (1) PL2563803T3 (es)
RS (1) RS54780B1 (es)
RU (1) RU2572595C2 (es)
SG (2) SG185032A1 (es)
SI (1) SI2563803T1 (es)
SM (1) SMT201600139B (es)
UA (1) UA112746C2 (es)
WO (1) WO2011134954A1 (es)
ZA (1) ZA201208092B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011083725A1 (de) 2011-09-29 2013-04-04 Bayer Pharma AG Estra-1,3,5(10),16-tetraen-3-carboxamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
KR102359214B1 (ko) 2014-04-04 2022-02-07 델 마 파마슈티컬스 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체
CN105017368B (zh) * 2015-06-26 2016-09-28 南通大学 人参二醇衍生物及其制备方法与应用
WO2017011318A1 (en) 2015-07-10 2017-01-19 University Of Miami Methods for treating mucopolysaccharidosis
CN105968167B (zh) * 2016-05-05 2017-10-17 江苏省中医药研究院 环氧蟾毒烯酮的制备方法及其作为抗肿瘤药物的用途
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
EP4104893B1 (en) 2020-12-17 2026-01-28 Aseptic Connectors Limited A connector
KR20230143159A (ko) * 2021-02-02 2023-10-11 뉴파마, 인크. 특정 화학 물질, 조성물 및 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577633A (en) * 1976-12-17 1980-10-29 Degussa Acyl derivatives of hellebrigenin
JPH04290899A (ja) * 1991-03-18 1992-10-15 Sankyo Co Ltd カルデノライド化合物
JPH05112596A (ja) * 1991-10-20 1993-05-07 Reisa Cho ブフアリンおよびブフアジエノリドを有効成分とす医薬
WO2000047215A2 (en) * 1999-02-12 2000-08-17 Cellpath, Inc. Methods for anti-tumor therapy
IL135707A0 (en) 2000-04-17 2001-05-20 Yissum Res Dev Co 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
AU2001282088A1 (en) * 2000-08-17 2002-02-25 Terness, Peter Immunosuppressive, antiinflammatory and analgetic compounds
CA2418458A1 (fr) 2003-02-06 2004-08-06 Neokimia Inc. Synthese totale de 14 beta-fluorosteroides via la reaction de diels-alder transannulaire
GB0509829D0 (en) 2005-05-13 2005-06-22 Guys And St Thomas Nhs Foundat Compound
CN100384830C (zh) * 2006-01-12 2008-04-30 天津药物研究院 环黄芪醇类衍生物以及用途
US20090018088A1 (en) * 2006-10-27 2009-01-15 University Of Louisville Research Foundation Treating cancer with cardiac glycosides
EP2032143A1 (en) * 2006-05-09 2009-03-11 University Of Louisville Research Foundation, Inc. Treating cancer with cardiac glycosides

Also Published As

Publication number Publication date
US20130040921A1 (en) 2013-02-14
ES2574205T3 (es) 2016-06-15
SG185032A1 (en) 2012-11-29
MY162934A (en) 2017-07-31
CN102947322A (zh) 2013-02-27
DK2563803T3 (en) 2016-05-30
CN102947322B (zh) 2016-09-07
UA112746C2 (uk) 2016-10-25
EP2563803A1 (en) 2013-03-06
JP5815675B2 (ja) 2015-11-17
KR20130118730A (ko) 2013-10-30
PL2563803T3 (pl) 2016-08-31
BR112012027393B1 (pt) 2020-12-29
ME02488B (me) 2017-02-20
EP2563803B1 (en) 2016-03-09
RS54780B1 (sr) 2016-10-31
KR101855453B1 (ko) 2018-06-20
CA2797468A1 (en) 2011-11-03
US8962602B2 (en) 2015-02-24
IL222707A0 (en) 2012-12-31
RU2012150501A (ru) 2014-06-10
CL2012003006A1 (es) 2013-10-18
HUE028751T2 (en) 2017-01-30
HRP20160523T1 (hr) 2016-06-03
SMT201600139B (it) 2016-07-01
SG10201503290TA (en) 2015-06-29
BR112012027393A2 (pt) 2017-08-08
HK1183036A1 (zh) 2013-12-13
NZ603261A (en) 2014-12-24
WO2011134954A1 (en) 2011-11-03
RU2572595C2 (ru) 2016-01-20
CY1117541T1 (el) 2017-04-26
IL222707B (en) 2018-06-28
CA2797468C (en) 2018-04-24
JP2013525403A (ja) 2013-06-20
ZA201208092B (en) 2014-03-26
SI2563803T1 (sl) 2016-06-30
AU2011247634B2 (en) 2016-07-07

Similar Documents

Publication Publication Date Title
MX2012012523A (es) Lactonas esteroideas anticancerigenas insaturadas en la posicion 7(8).
PH12016502066A1 (en) Methods of treating bladder cancer
MX2021016058A (es) Analogos sinteticos de las ecteinascidinas y su uso como agentes antitumorales.
TW201611831A (en) Novel antitumoral use of CABAZITAXEL
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
PH12015501088A1 (en) Dimeric compounds
PH12013500885B1 (en) Pesticidal compositions and processes related thereto
WO2012139039A3 (en) Bisphenol compounds and methods for their use
MX2015012743A (es) Compuesto de pirazol-amida y sus usos farmaceuticos.
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
MX2011011431A (es) Composicion para el tratamiento de cancer de prostata.
WO2014089177A3 (en) Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
EA201270728A1 (ru) Пуриновые соединения
MX2015015755A (es) Derivados de perhidroquinoxalina utiles como analgesicos.
PH12015500399A1 (en) Azaindolines
WO2012061012A3 (en) 4-amino-2h-pyran-2-one analogs as anticancer agents
MY148651A (en) Antitumoral compounds
MX348147B (es) Biarilsulfonamidas utiles en el tratamiento de la inflamacion y cancer.
MX2011006532A (es) Compuestos anticancerigenos.
WO2010149688A3 (en) Antitumoral compounds
IN2013DE03665A (es)
NZ594996A (en) Cholestanol derivative for combined use
PH12015500306A1 (en) Arry-520 for use in treating cancer in a patient with low aag
JO3550B1 (ar) مركب لمعالجة سرطان البروستاتا
UA82243U (ru) Соединение n-пара-бромфенил-3(-уридин-6'-амино)-сукцинимид с потенциальными физиологическими свойствами

Legal Events

Date Code Title Description
FG Grant or registration